Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth A Overmoyer

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Breast Cancer|February 6, 2010
Inflammatory breast cancer: novel preoperative therapiesBeth A Overmoyer
Current Oncology Reports|August 16, 2019
Inflammatory Breast Cancer: a Separate EntityJennifer M Rosenbluth, Beth A Overmoyer
Breast Cancer Research and Treatment|December 14, 2005
Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancerBrenda W Cooper, Tomas Radivoyevitch, Beth A Overmoyer, et al.
The American Journal of Surgical Pathology|July 3, 2025
The Clinicopathologic Features of Inflammatory Breast Carcinoma (IBC) With Lobular FeaturesS Emily Bachert, Allison M Onken, Allison S Cleary, et al.
Annals of Surgical Oncology|September 8, 2012
Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomyDanielle N Margalit, Meera Sreedhara, Yu-Hui Chen, et al.
Annals of Surgical Oncology|March 21, 2015
Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional ManagementLaura E G Warren, Hao Guo, Meredith M Regan, et al.
Cancer|April 2, 2019
Prevalence of germline variants in inflammatory breast cancerHuma Q Rana, Rosalba Sacca, Christine Drogan, et al.
Breast Cancer Research and Treatment|April 21, 2015
Inflammatory breast cancer and development of brain metastases: risk factors and outcomesLaura E G Warren, Hao Guo, Meredith M Regan, et al.
American Journal of Clinical Oncology|June 21, 2021
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast CancerKelly A Hirko, Meredith M Regan, Marie C Remolano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancerKathy D Miller, Linnea I Chap, Frankie A Holmes, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Breast Cancer|February 6, 2010
Inflammatory breast cancer: novel preoperative therapiesBeth A Overmoyer
Current Oncology Reports|August 16, 2019
Inflammatory Breast Cancer: a Separate EntityJennifer M Rosenbluth, Beth A Overmoyer
Breast Cancer Research and Treatment|December 14, 2005
Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancerBrenda W Cooper, Tomas Radivoyevitch, Beth A Overmoyer, et al.
The American Journal of Surgical Pathology|July 3, 2025
The Clinicopathologic Features of Inflammatory Breast Carcinoma (IBC) With Lobular FeaturesS Emily Bachert, Allison M Onken, Allison S Cleary, et al.
Annals of Surgical Oncology|September 8, 2012
Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomyDanielle N Margalit, Meera Sreedhara, Yu-Hui Chen, et al.
Annals of Surgical Oncology|March 21, 2015
Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional ManagementLaura E G Warren, Hao Guo, Meredith M Regan, et al.
Cancer|April 2, 2019
Prevalence of germline variants in inflammatory breast cancerHuma Q Rana, Rosalba Sacca, Christine Drogan, et al.
Breast Cancer Research and Treatment|April 21, 2015
Inflammatory breast cancer and development of brain metastases: risk factors and outcomesLaura E G Warren, Hao Guo, Meredith M Regan, et al.
American Journal of Clinical Oncology|June 21, 2021
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast CancerKelly A Hirko, Meredith M Regan, Marie C Remolano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancerKathy D Miller, Linnea I Chap, Frankie A Holmes, et al.
Pageof 3